Biosyent Intangible Assets vs Total Assets Analysis

RX Stock  CAD 11.52  0.18  1.54%   
Biosyent financial indicator trend analysis is way more than just evaluating Biosyent prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biosyent is a good investment. Please check the relationship between Biosyent Intangible Assets and its Total Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biosyent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Intangible Assets vs Total Assets

Intangible Assets vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biosyent Intangible Assets account and Total Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Biosyent's Intangible Assets and Total Assets is 0.65. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Total Assets in the same time period over historical financial statements of Biosyent, assuming nothing else is changed. The correlation between historical values of Biosyent's Intangible Assets and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Biosyent are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Intangible Assets i.e., Biosyent's Intangible Assets and Total Assets go up and down completely randomly.

Correlation Coefficient

0.65
Relationship DirectionPositive 
Relationship StrengthSignificant

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Total Assets

Total assets refers to the total amount of Biosyent assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biosyent books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Biosyent's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biosyent current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biosyent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Biosyent's Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 11.61 in 2024, whereas Selling General Administrative is likely to drop slightly above 6 M in 2024.
 2021 2022 2023 2024 (projected)
Total Revenue28.6M27.9M31.6M33.2M
Depreciation And Amortization457.1K451.0K455.3K478.1K

Biosyent fundamental ratios Correlations

-0.04-0.240.961.00.78-0.51.00.960.570.930.150.990.150.830.59-0.140.961.00.250.650.40.960.86-0.640.61
-0.040.41-0.1-0.03-0.08-0.41-0.09-0.090.37-0.190.130.020.94-0.260.07-0.5-0.1-0.02-0.950.140.33-0.07-0.270.450.12
-0.240.41-0.11-0.26-0.220.08-0.28-0.15-0.11-0.32-0.16-0.230.36-0.14-0.210.0-0.15-0.23-0.42-0.260.17-0.32-0.220.2-0.21
0.96-0.1-0.110.940.78-0.390.950.990.460.90.020.930.090.890.48-0.120.990.960.320.510.480.910.87-0.750.47
1.0-0.03-0.260.940.76-0.521.00.950.580.930.150.990.160.820.59-0.140.941.00.230.680.370.960.85-0.620.65
0.78-0.08-0.220.780.76-0.430.770.740.530.780.450.78-0.030.60.8-0.010.870.780.230.290.540.680.62-0.60.1
-0.5-0.410.08-0.39-0.52-0.43-0.49-0.32-0.99-0.31-0.2-0.61-0.380.02-0.560.42-0.41-0.520.37-0.66-0.61-0.350.0-0.16-0.48
1.0-0.09-0.280.951.00.77-0.490.960.560.930.130.990.110.830.59-0.110.951.00.290.660.360.960.87-0.650.63
0.96-0.09-0.150.990.950.74-0.320.960.40.910.020.930.120.920.44-0.070.970.960.320.520.370.950.92-0.760.52
0.570.37-0.110.460.580.53-0.990.560.40.390.240.680.340.060.63-0.390.50.59-0.310.650.650.420.080.070.46
0.93-0.19-0.320.90.930.78-0.310.930.910.390.240.880.020.880.55-0.020.920.910.370.540.320.880.87-0.670.52
0.150.13-0.160.020.150.45-0.20.130.020.240.240.160.07-0.040.72-0.090.130.13-0.180.18-0.120.040.010.250.06
0.990.02-0.230.930.990.78-0.610.990.930.680.880.160.180.740.64-0.180.940.990.170.70.450.930.79-0.570.64
0.150.940.360.090.16-0.03-0.380.110.120.340.020.070.180.00.04-0.580.060.16-0.870.230.270.15-0.040.290.27
0.83-0.26-0.140.890.820.60.020.830.920.060.88-0.040.740.00.260.030.860.820.470.320.140.870.95-0.840.38
0.590.07-0.210.480.590.8-0.560.590.440.630.550.720.640.040.26-0.140.590.590.020.350.290.450.35-0.20.22
-0.14-0.50.0-0.12-0.14-0.010.42-0.11-0.07-0.39-0.02-0.09-0.18-0.580.03-0.14-0.09-0.150.46-0.3-0.17-0.10.1-0.26-0.22
0.96-0.1-0.150.990.940.87-0.410.950.970.50.920.130.940.060.860.59-0.090.960.310.480.510.890.85-0.740.41
1.0-0.02-0.230.961.00.78-0.521.00.960.590.910.130.990.160.820.59-0.150.960.230.660.410.960.85-0.630.62
0.25-0.95-0.420.320.230.230.370.290.32-0.310.37-0.180.17-0.870.470.020.460.310.23-0.05-0.230.30.49-0.66-0.02
0.650.14-0.260.510.680.29-0.660.660.520.650.540.180.70.230.320.35-0.30.480.66-0.050.170.620.390.020.91
0.40.330.170.480.370.54-0.610.360.370.650.32-0.120.450.270.140.29-0.170.510.41-0.230.170.230.08-0.22-0.01
0.96-0.07-0.320.910.960.68-0.350.960.950.420.880.040.930.150.870.45-0.10.890.960.30.620.230.91-0.70.61
0.86-0.27-0.220.870.850.620.00.870.920.080.870.010.79-0.040.950.350.10.850.850.490.390.080.91-0.830.47
-0.640.450.2-0.75-0.62-0.6-0.16-0.65-0.760.07-0.670.25-0.570.29-0.84-0.2-0.26-0.74-0.63-0.660.02-0.22-0.7-0.83-0.01
0.610.12-0.210.470.650.1-0.480.630.520.460.520.060.640.270.380.22-0.220.410.62-0.020.91-0.010.610.47-0.01
Click cells to compare fundamentals

Biosyent Account Relationship Matchups

Biosyent fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets31.0M33.6M37.2M40.5M41.5M43.6M
Other Current Liab198.8K328.8K98.7K318.0K138.4K228.7K
Total Current Liabilities3.4M5.1M4.1M5.7M5.5M5.8M
Total Stockholder Equity25.8M26.8M31.6M33.4M34.8M36.5M
Property Plant And Equipment Net2.5M2.2M1.9M1.7M1.4M1.5M
Net Debt(11.6M)(18.6M)(16.5M)(6.5M)(3.7M)(3.9M)
Retained Earnings17.5M19.1M24.1M25.9M27.5M28.9M
Accounts Payable2.9M3.7M3.6M5.1M5.1M5.3M
Cash13.4M20.3M18.0M7.9M4.9M5.4M
Non Current Assets Total4.1M3.8M3.1M3.3M5.7M5.9M
Cash And Short Term Investments22.0M25.6M28.2M28.7M26.2M27.5M
Common Stock Shares Outstanding13.9M13.1M12.9M12.5M12.2M13.5M
Liabilities And Stockholders Equity31.0M33.6M37.2M40.5M41.5M43.6M
Inventory2.1M2.1M2.2M4.5M5.9M6.2M
Other Current Assets648.8K307.6K456.0K255.0K243.5K163.3K
Other Stockholder Equity1.2M1.5M1.8M2.2M2.3M3.1M
Total Liab5.2M6.8M5.6M7.1M6.8M7.1M
Total Current Assets26.8M29.8M34.1M37.1M35.9M37.7M
Intangible Assets1.0M1.0M874.0K1.2M1.2M660.8K
Current Deferred Revenue99.1K934.4K313.6K164.4K134.5K138.0K
Net Receivables2.1M1.8M3.2M3.7M3.5M3.7M
Accumulated Other Comprehensive Income(105.3K)(166.7K)(185.3K)(143.1K)(177.5K)(168.6K)
Short Term Investments8.5M5.3M10.2M20.8M21.3M22.3M
Common Stock7.2M6.4M5.8M5.4M5.1M5.4M
Other Liab102.9K79.7K80.2K182.4K209.7K153.4K
Net Tangible Assets24.7M25.8M30.7M32.3M37.1M21.9M
Other Assets686.5K758.8K406.5K639.1K1.00.95
Non Current Liabilities Total1.8M1.6M1.5M1.4M1.2M851.1K
Property Plant Equipment2.4M2.1M1.8M1.6M1.9M961.5K
Deferred Long Term Liab72.0K131.0K124.1K170.6K196.2K98.8K
Net Invested Capital25.8M26.8M31.6M33.4M34.8M31.8M
Net Working Capital23.5M24.6M29.9M31.4M30.3M29.1M
Capital Stock7.2M6.4M5.8M5.4M5.1M5.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Biosyent Stock Analysis

When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.